Wednesday, 7 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Aurobindo Pharma Ltd

NSE: AUROPHARMA · BSE: 524804 · Pharmaceuticals & Biotechnology · 63 announcements

Aurobindo Pharma Ltd news stories on ALFA NewsRead the news →
Share price
₹1,682.00
Market cap
₹97,691 Cr
Revenue (annual)
₹33,653 Cr
Net profit (annual)
₹3,505 Cr
P/E (TTM)
24.8×Sector 47.4×
Promoter holding
51.88%+0.06% QoQ
FII holding
16.38%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

20:43 IST NSE
Results Update

Aurobindo Pharma Results Update

Aurobindo Pharma reported Q4FY26 revenue of ₹8,853 Crore, a 5.6% YoY increase. Net profit rose 2.0% to ₹921 Crore, supported by strong European business growth.

Value
₹8,853 Cr